1. Home
  2. BCLI vs LFWD Comparison

BCLI vs LFWD Comparison

Compare BCLI & LFWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCLI
  • LFWD
  • Stock Information
  • Founded
  • BCLI 2000
  • LFWD 2001
  • Country
  • BCLI United States
  • LFWD Israel
  • Employees
  • BCLI N/A
  • LFWD N/A
  • Industry
  • BCLI Biotechnology: Biological Products (No Diagnostic Substances)
  • LFWD
  • Sector
  • BCLI Health Care
  • LFWD
  • Exchange
  • BCLI Nasdaq
  • LFWD NYSE
  • Market Cap
  • BCLI 37.7M
  • LFWD 31.8M
  • IPO Year
  • BCLI N/A
  • LFWD 2014
  • Fundamental
  • Price
  • BCLI $0.35
  • LFWD $3.80
  • Analyst Decision
  • BCLI Strong Buy
  • LFWD Strong Buy
  • Analyst Count
  • BCLI 1
  • LFWD 1
  • Target Price
  • BCLI $2.00
  • LFWD $13.00
  • AVG Volume (30 Days)
  • BCLI 497.9K
  • LFWD 23.5K
  • Earning Date
  • BCLI 08-12-2024
  • LFWD 08-28-2024
  • Dividend Yield
  • BCLI N/A
  • LFWD N/A
  • EPS Growth
  • BCLI N/A
  • LFWD N/A
  • EPS
  • BCLI N/A
  • LFWD N/A
  • Revenue
  • BCLI N/A
  • LFWD $17,907,000.00
  • Revenue This Year
  • BCLI N/A
  • LFWD $126.93
  • Revenue Next Year
  • BCLI N/A
  • LFWD $89.06
  • P/E Ratio
  • BCLI N/A
  • LFWD N/A
  • Revenue Growth
  • BCLI N/A
  • LFWD 205.32
  • 52 Week Low
  • BCLI $0.13
  • LFWD $3.41
  • 52 Week High
  • BCLI $1.90
  • LFWD $9.10
  • Technical
  • Relative Strength Index (RSI)
  • BCLI 40.33
  • LFWD 34.88
  • Support Level
  • BCLI $0.33
  • LFWD $3.60
  • Resistance Level
  • BCLI $0.38
  • LFWD $3.85
  • Average True Range (ATR)
  • BCLI 0.03
  • LFWD 0.24
  • MACD
  • BCLI 0.00
  • LFWD 0.04
  • Stochastic Oscillator
  • BCLI 16.30
  • LFWD 68.42

About BCLI Brainstorm Cell Therapeutics Inc.

Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.

About LFWD REWALK ROBOTICS LTD

Rewalk Robotics Ltd is a medical device company that designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering functional and health benefits in clinical settings as well as in the home and community. Its product offerings are the ReWalk Personal and ReWalk Rehabilitation Exoskeleton devices for individuals with spinal cord injury. It operates through markets in the United States and Europe with some lesser sales in Asia, the Middle East and South America.

Share on Social Networks: